Viewing Study NCT06627751


Ignite Creation Date: 2025-12-24 @ 11:46 PM
Ignite Modification Date: 2026-01-01 @ 10:13 PM
Study NCT ID: NCT06627751
Status: SUSPENDED
Last Update Posted: 2025-11-17
First Post: 2024-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mezigdomide, Carfilzomib, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma in Patients With Extramedullary Disease
Sponsor: Roswell Park Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module